Comparative study of Bilvadi vati and Haridradi vati in Obesity (Sthaulya)

A comparative clinical study of efficacy of Bilvadi vati with Haridradi vati in Sthaulya

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/06/008886

Enrollment

Registered

2017-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients of obesity having all the symptoms

Interventions

Intervention1: Bilvadi vati: Bilvadi vati 1500 mg B.I.D. orally With honey pragbhakt time, total duration 3 months Control Intervention1: Haridradi vati: 1500 mg B.I.D. orally With honey pragbhakt tim

Eligibility

Inclusion criteria

Inclusion criteria: 1) The patients having sign and symptoms of sthaulya according to Charak Samhita Sutrasthan 21/9 2) The patients of Sthaulya i.e. those have BMI more than 25 and upto 40 including overweight, obese class I, II, III. 3) Waist to hip ratio more than 1.0 4) Lipid profile

Exclusion criteria

Exclusion criteria: 1)pregnant woman 2)Acute life threatening condition like CVA, Acute MIetc. 3) hypothyroidism

Design outcomes

Primary

Measure	Time frame
A comparative clinical study of efficacy of Bilvadi vati with Haridradi vati in SthaulyaTimepoint: 3 months	—

Secondary

Measure	Time frame
To study the changes in lipid profile by Bilvadi vatiTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Yogesh T Kotangale

MUHS NASHIK

kavita.kv28@gmail.com9960874377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026